(4aR,7aS)-octahydro-1H-cyclopentabpiperazine,1310377-65-1-Amadis Chemical

Home > Product Catalog > All > (4aR,7aS)-octahydro-1H-cyclopentabpiperazine

[CAS No.1310377-65-1] A1024199 (4aR,7aS)-octahydro-1H-cyclopentabpiperazine 97%

Search after editing

Catalog No.: A1024199

Cas No.: 1310377-65-1

Molecular Formula: C₇H₁₄N₂

Molecular Weight: 126.20

MDL NO: MFCD31693640

EINECS:

Order & Inquiry & Tech Support

Tel: 0086-571-89925085
Order & Inquiry: sales@amadischem.com
Tech Support: tech@amadischem.com

Bulk Inqulry

*All chemicals from Amadis Chemical are for laboratory or manufacturing use only.

Quality Control of [1310377-65-1]

NMR

CNMR

HPLC

LC-MS

Related Doc. of[1310377-65-1]

SDS

Specification

MOL

SDF

Product Details [1310377-65-1]

Synonyms:

Melting point:

Storage: Store in 2-8°C for long term (months)

Smiles: N1CCN[C@H]2CCC[C@@H]12

Appearance:

Inchi: InChI=1S/C7H14N2/c1-2-6-7(3-1)9-5-4-8-6/h6-9H,1-5H2/t6-,7+

Boiling point:

Flash point:

Pubchem ID: 93503370

InchiKey: HIWGVEJBTWMJEP-KNVOCYPGSA-N

Safety [1310377-65-1]

Precautionary statements:

Signal word:

Danger Category:

Packing Group:

UN No.:

Pictogram:

Literatures [1310377-65-1]

Sorry, the literature is not available.

Similar of [1310377-65-1]

A1015348 32736-19-9

2-Ethyl-6-methyl-piperazine

Reason:All

A1086387 393781-72-1

(2R)-2-ethylpiperazine

Reason:All

A1083142 23703-03-9

2,5-diethylpiperazine

Reason:All

A938388 682740-57-4

(2R,6R)-2,6-Diethylpiperazine

Reason:All

A1030011 1146290-16-5

1-(piperazin-2-yl)propan-2-amine

Reason:All

A2626 124695-93-8

Azepan-3-yl-methyl-amine

Reason:All

A1020134 118948-26-8

cis-Decahydro-quinoxaline

Reason:All

A1022858 1260595-54-7

(1R,4R)-2,5-Diazabicyclo(2.2.2)octane

Reason:All

A1019158 1187929-76-5

(S)-1-Cyclopentyl-3-methyl-piperazine

Reason:All

A1093613 90000-28-5

2-propylpiperazine

Reason:All

Description [1310377-65-1]

Sorry, the product description is not available.

Browsing history

A1287600 1782218-59-0

[1H-indene-1,4'-piperidine], 6-bromo-2,3-dihydro-

Inquiry

Detail